IC BLUE LIMITED
Company number 04415750 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: IC Blue Limited
1. Financial Health Score: C+
Explanation: IC Blue Limited exhibits a mixed clinical picture. The company maintains a positive net asset position and has demonstrated longevity since 2002, but presents several concerning symptoms: declining net assets over consecutive years, increasing reliance on short-term credit facilities, and a current ratio that is deteriorating. While not in immediate critical condition, the trend lines suggest the business is experiencing chronic financial strain that requires attention.
2. Key Vital Signs
Balance Sheet Strength: Moderate but Weakening
| Metric | 2025 | 2024 | 2023 | Trend |
|---|---|---|---|---|
| Net Assets | £1,033,161 | £1,191,005 | £1,551,118 | 📉 Declining |
| Total Assets | £2,874,546 | £2,789,093 | £3,288,366 | 📉 Declining |
| Cash | £136,823 | £51,314 | £495,513 | ⚠️ Volatile |
| Current Liabilities | £1,814,815 | £1,482,928 | £1,820,065 | 📈 Rising |
Interpretation: The patient's "bone density" (net assets) has eroded by approximately 33% from the 2023 peak of £1.55M to the current £1.03M. This represents a sustained loss of financial mass that warrants investigation.
Liquidity Ratios: Adequate but Under Pressure
| Ratio | 2025 | 2024 | Healthy Range | Status |
|---|---|---|---|---|
| Current Ratio | 1.44 | 1.70 | 1.5-2.0 | ⚠️ Marginal |
| Quick Ratio (ex-stock) | 0.80 | 0.92 | >1.0 | 🔴 Below par |
| Cash to Current Liabilities | 7.5% | 3.5% | >20% | 🔴 Weak |
Interpretation: The current ratio sits just below the healthy threshold and has declined year-on-year. More concerning is the quick ratio below 1.0, meaning that if stock could not be readily converted to cash, the company could not meet its short-term obligations from liquid assets. The cash-to-liabilities ratio is worryingly low, like having barely enough blood pressure to sustain vital organs.
Leverage Position: Moderate
| Metric | 2025 | 2024 |
|---|---|---|
| Total Liabilities / Total Assets | 63.1% | 53.1% |
| Equity Cushion (Net Assets / Total Assets) | 35.9% | 42.7% |
Interpretation: The leverage has increased meaningfully. The equity cushion has thinned from 42.7% to 35.9%, meaning creditors now fund a larger proportion of the business. This is like a patient whose cholesterol has risen – not immediately dangerous, but trending in the wrong direction.
Working Capital: Positive but Declining
- Net Current Assets: £793,528 (down from £1,042,075 – a 23.9% decline)
- Stock: £1,153,783 (stable, representing 40% of total assets)
- Trade Debtors: £1,267,695 (slight increase)
Interpretation: Working capital remains positive, which keeps the business out of the emergency room. However, the 24% decline in one year is a significant hemorrhage that cannot continue indefinitely without consequences.
3. Diagnosis
Primary Condition: Chronic Profitability Erosion
The financial data tells a story of a business that is gradually consuming its own capital reserves. The P&L reserve has declined from £1,189,005 to £1,031,161 – a reduction of £157,844. This suggests the company is trading at a loss when dividends are taken into account.
The arithmetic: Dividends of £81,882 were paid, meaning the underlying trading loss was approximately £157,844 + £81,882 = approximately £239,726 (before accounting for any movements in reserves). This is a significant loss for a company of this size.
Secondary Conditions Identified:
1. Invoice Financing Dependency (Growing) The secured invoice financing facility has increased from £429,613 to £728,242 – a 70% increase. This represents the business increasingly "borrowing against its future" to fund current operations. Like a patient becoming dependent on pain medication, this can mask underlying problems while creating new vulnerabilities.
2. Trade Creditor Stretching Trade creditors have increased from £490,017 to £652,284 (33% increase), while stock levels remain stable. This may indicate the company is taking longer to pay suppliers – a common symptom of cash flow pressure.
3. Related Party Exposure - £48,000 annual rent paid to IC Blue Technology Limited (common control) - £139,467 in purchases from Leeds Electronic Manufacturing Services Limited (up from £87,831) - Small inter-company balances exist
These related party transactions require monitoring to ensure they are conducted on arm's length terms and not draining resources from the business.
4. Director Loan Matthew Ward has an outstanding loan of £17,684 (reduced from £41,739). While reducing, an interest-free, unsecured director loan represents capital that could be deployed in the business.
Positive Indicators:
✅ Long-term debt eliminated – The £91,667 in long-term bank loans has been cleared ✅ Cash position improved – Cash increased from £51,314 to £136,823 (167% increase) ✅ Stable workforce – 36 employees maintained ✅ Consistent dividend – £81,882 paid, suggesting director confidence in sustainability ✅ Long-established – Operating since 2002, demonstrating resilience
The 2022 Anomaly
The 2022 financial year stands out dramatically with £39.6M turnover and £11.5M in total assets. This appears to have been an exceptional year, possibly driven by a major contract or supply chain opportunity. The subsequent contraction to current levels suggests the business has returned to its more typical operating scale. This "fever spike" in activity makes trend analysis challenging but underscores that the company can scale significantly when opportunities arise.
4. Recommendations
Immediate Actions (0-3 months)
1. Cash Flow Stabilization The company should prepare a detailed 13-week cash flow forecast. With only £136,823 in cash against £1.8M in current liabilities, any disruption to debtor collection or a major customer loss could create a liquidity crisis. Consider whether invoice financing terms can be optimized.
2. Debtor Management Trade debtors of £1.27M represent approximately 47 days of operating costs (estimated). Implement rigorous credit control procedures to accelerate collection. Even reducing debtor days by 10% would release approximately £127,000 in cash.
3. Review Dividend Policy Paying £81,882 in dividends while the P&L reserve declines by £157,844 is effectively distributing capital rather than profits. The shareholders should consider suspending or reducing dividends until profitability is restored.
Medium-Term Actions (3-12 months)
4. Profitability Analysis Conduct a thorough margin analysis by product line and customer. The wholesale electronics distribution sector typically operates on thin margins, and the company needs to identify which activities are generating positive contributions and which are consuming resources.
5. Stock Optimization Stock of £1.15M represents over 40% of total assets. Review stock turn rates and identify slow-moving or obsolete inventory. In the electronics component industry, inventory can become obsolete quickly, and carrying excess stock ties up valuable working capital.
6. Related Party Review Ensure all transactions with IC Blue Technology Limited and Leeds Electronic Manufacturing Services Limited are conducted on commercial terms and properly documented. The increase in purchases from Leeds EMS from £87,831 to £139,467 should be justified by business need, not group convenience.
Strategic Considerations (12+ months)
7. Business Model Assessment The dramatic variance between 2022 and subsequent years raises questions about the sustainability of the current business model. The company should evaluate whether it can build more recurring revenue streams rather than relying on large, one-off opportunities.
8. Capital Structure Review With increasing reliance on invoice financing and rising current liabilities, consider whether a more permanent capital structure (perhaps including longer-term debt or equity) would provide greater stability and reduce refinancing risk.
9. Succession and Governance With Mr. Andrew Lucas owning more than 75% of shares and three directors, ensure that key-person risk is managed and that the business can continue without disruption if any director becomes unavailable.
Summary Assessment
| Category | Rating | Notes |
|---|---|---|
| Balance Sheet Health | C+ | Positive but declining |
| Liquidity | C | Quick ratio below 1.0 |
| Profitability | D | Evident losses in P&L reserve |
| Cash Management | C- | Improving but still thin |
| Long-term Viability | B- | Established business with resilience |
| Overall | C+ | Surviving but needs treatment |